- Filter by
- Categories
- Tags
- Show all
- Article
- Confusion
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Obviousness
- Opposition
- Passing Off
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Prosecution
- Services
- Summary
- Trade Secrets
- Trade-mark
- Use
- Validity
- 3D printing
- 6.08
- abandonment
- abstract
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- agreements
- airport security
- ambiguity
- amending
- amendment
- Amendments
- annual maintenance fee
- Anticipation
- application
- application chain
- application fee
- arbitrary
- arbitration
- Assignment
- Australia
- bad faith
- bill
- Bill C-31
- Bill C-43
- Bill C-8
- Bill C-86
- biologics
- Biotech Patents
- book launch
- border measures
- brand
- broadcasting
- budget
- burden of proof
- calculation
- call processing
- Canada
- Canada Gazette
- canadian patent law
- causal link
- cdrp
- CEEO
- certificate of supplementary protection
- champerty
- chemical patent
- ciba
- CIPO
- cira
- Claim Construction
- Class Actions
- college of agents
- combination
- combination drugs
- commissioner
- Common General Knowledge
- complete code
- confidential
- Confidential Information
- confidentiality
- confidentiality order
- conflict of interest
- conflicts
- conflicts of interest
- confusing
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- contract
- contributory infringement
- Copyright
- copyright infringement
- copyright test
- Costs
- counsel
- CSP
- damages
- Data
- Data Protection
- deadline
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- design patents
- designs
- deviation
- digital infringement
- disclosure
- distinctive
- distinctive feature
- distinctiveness
- diversity
- division of powers
- DNA Patents
- domain
- domain names
- dosage range
- Double Patenting
- doubtful cases
- due care
- e-commerce
- Early dismissal
- errors
- essentiality of elements
- Ethics
- Europe
- Evidence
- examination quality
- examination statistics
- expert
- expert blinding
- expert evidence
- Experts
- expiry
- Expungement
- extraterritoriality
- federal court
- federal court of appeal
- fee
- fees
- file wrapper
- filing
- filing fee
- financial services
- foreign issue estoppel
- forum selection
- fraud
- Free World Trust
- funding
- future infringement
- generics
- geographical indications
- global
- Good Faith
- government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- human use
- ICSID
- Illegality
- Improver
- imunity
- Indefiniteness
- Inducement
- industrial designs
- infringement
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- intellectual property
- intellectual property rights
- intent
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP
- IP management
- ip regime
- IP Strategy
- IPO
- ISP
- IT patent
- ITC
- Jurisdiction
- Late fee
- law
- law firm
- Legal Retainer
- legal test
- legislative reform
- legitimate interest
- license
- licensee
- Licensing
- limitation periods
- litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- Methods of Medical Treatment
- minister of health
- minorities
- misleading
- monopoly
- motion
- Motion to dismiss
- Motion to strike
- NAFTA
- national phase entry
- new act
- no chance of success
- non-infringing alternative
- non-statutory subject matter
- notice of allegation
- notice to rectify
- novelty
- obvious to try
- Obviousness
- official mark
- official marks
- on-sale
- on-sale bar
- Online
- ontario
- opposition
- outsourcing
- Overbreadth
- overlapping
- overpromising
- ownership
- Ownership & Inventorship
- PAB
- Passing Off
- Patent
- patent act
- patent agent
- Patent Agents
- patent appeal board
- patent application
- patent book
- patent eligibility
- patent infrigement
- patent infringement
- patent law
- patent litigation
- Patent Office
- patent ownership
- patent practicioner
- patent protection
- patent rules
- Patent Strategy
- patent term adjustment
- patent trolls
- Patentable Subject Matter
- patented medicines
- patented medicines prices review board
- patentee
- patents
- PCT
- pharma
- pharmaceutical
- pharmaceutical patent
- pharmaceutical pricing
- plain and obvious
- PLT
- PM(NOC)
- PM(NOC) Damages
- PMNOC Regulations
- PMPRB
- posita
- price regulation
- prices
- prior art
- prior disclosure
- prior disclosure defence
- prior use
- priority
- priority claim
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- prohibited marks
- Promise
- promise doctrine
- proprietor
- prosecution
- protective order
- prothonotaries
- provisional patent
- public sale
- Public Servant
- Punitive Damages
- quantification
- ramped-up sales
- recognition
- Records
- registration
- reinstatement
- relevant date for construction
- remedies
- representation
- requisition
- responding
- risk
- Royalties
- s. 27
- s. 45
- s. 53
- sale
- SCOTUS
- second person
- Secondary Infringement
- secondary meaning
- secret sale
- section 101
- section 28
- Section 45
- section 50
- Section 52
- section 56
- section 7
- security
- selection patents
- seminar
- Services
- settlement
- skilled person
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- springboard profits
- SRED
- Standard of Review
- standing
- standing to appeal
- Startups
- statute of monopolies
- statutory subject matter
- strategy
- subject matter
- Sufficiency
- Summary Judgment
- summary trial
- supreme court
- surname
- swiss
- tadalafil
- third party
- time frame
- top patent agent
- TPP
- trade secrets
- trade-mark
- Trade-mark Infringement
- Trade-mark Licensing
- Trade-mark Use
- trade-marks act
- trademark
- Trademark Act
- trademark agent
- trademarks
- Trademarks use
- treaty
- UK
- United States
- unpatentable
- untrue material allegation
- US
- use
- useful article
- USMCA
- USPTO
- Utility
- validity
- variant
- Varying records
- veterinary use
- wenger
- who's who legal
- women
April 5, 2016
April 5, 2016
2015 FC 125 - The existing patent was invalid on the grounds of lack of utility for having made a promise of utility that could not be demonstrated nor soundly predicted, was anticipated by a previous patent of the applicant that claimed an overlapping dosage range, and was also therefore made obvious by the same previous patent.
March 3, 2015
March 3, 2015
Alcon Canada Inc v Cobalt Pharmaceuticals Company, 2014 FC 149 - The Court examined in detail a number of experiments disclosed in the patent that were said to establish the claimed utility, but the experiments did not demonstrate or soundly predict utility for the broad ranges of molecular weight and chemical concentration claimed.
November 21, 2014
November 21, 2014
Apotex Inc v Pfizer Canada Inc, 2014 FCA 250 - The Court rejected Apotex’s sweeping argument that any given promise in the patent must be construed as overarching to all of the patent’s claims.
October 27, 2014
October 27, 2014
Dow Chemical Co v NOVA Chemicals Corp, 2014 FC 844 - The Federal Court found that NOVA Chemicals infringed Canadian Patent No. 2,160,705, owned by The Dow Chemical Company, by NOVA’s use of its “SURPASS” polyethylene product. Allegations of invalidity for lack of utility, claims broader than any invention made or disclosed, anticipation, obviousness, double patenting, and insufficiency of the specification were unsuccessful.
July 31, 2014
July 31, 2014
Allergan Inc v Apotex Inc, 2014 FC 567 - In terms of claim construction, this case shows the tension between construing claims based solely on the wording of the claims versus peering beyond the wording of the claims to distill an underlying invention.